GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...

So far, cabotegravir LA has been approved in the US, Australia, Zimbabwe, South Africa, and Malawi, said GSK.

GSK, Transnet, Telkom and the Development Bank of Southern Africa (DBSA). “Her outstanding track record in building meaningful relationships across diverse markets and categories makes her a ...